Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF
Santhera Pharmaceuticals Holding (SPHDF) Stock Price & Analysis
31 Followers
SPHDF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.80 - $13.35
Previous Close$11.7
Volume100.00
Average Volume (3M)N/A
Market Cap
$81.59M
Enterprise Value$112.52M
Total Cash (Recent Filing)CHF12.70M
Total Debt (Recent Filing)CHF40.64M
Price to Earnings (P/E)2.0
Beta-0.31
Next Earnings
Sep 04, 2024EPS Estimate
-$1.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.92
Shares Outstanding12,622,048
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation3.17
R-Squared0.02
Alpha0.70
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.18% Other Institutional Investors
99.82% Public Companies and
Individual Investors
SPHDF FAQ
What was Santhera Pharmaceuticals Holding’s price range in the past 12 months?
Santhera Pharmaceuticals Holding lowest stock price was $6.80 and its highest was $13.35 in the past 12 months.
What is Santhera Pharmaceuticals Holding’s market cap?
Currently, no data Available
When is Santhera Pharmaceuticals Holding’s upcoming earnings report date?
Santhera Pharmaceuticals Holding’s upcoming earnings report date is Sep 04, 2024 which is in 62 days.
How were Santhera Pharmaceuticals Holding’s earnings last quarter?
Santhera Pharmaceuticals Holding released its earnings results on Apr 25, 2024. The company reported -$1.306 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.306.
Is Santhera Pharmaceuticals Holding overvalued?
According to Wall Street analysts Santhera Pharmaceuticals Holding’s price is currently Overvalued.
Does Santhera Pharmaceuticals Holding pay dividends?
Santhera Pharmaceuticals Holding does not currently pay dividends.
What is Santhera Pharmaceuticals Holding’s EPS estimate?
Santhera Pharmaceuticals Holding’s EPS estimate is -$1.04.
How many shares outstanding does Santhera Pharmaceuticals Holding have?
Santhera Pharmaceuticals Holding has 12,624,907 shares outstanding.
What happened to Santhera Pharmaceuticals Holding’s price movement after its last earnings report?
Santhera Pharmaceuticals Holding reported an EPS of -$1.306 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Santhera Pharmaceuticals Holding?
Currently, no hedge funds are holding shares in SPHDF
---
Santhera Pharmaceuticals Holding Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
72.05%
12-Months-Change
Fundamentals
Return on Equity
522.00%
Trailing 12-Months
Asset Growth
89.11%
Trailing 12-Months
Company Description
Santhera Pharmaceuticals Holding
Santhera Pharmaceuticals Holding AG is a specialty pharmaceutical company focused on the development and commercialization of products for the treatment of mitochondrial and neuromuscular diseases, an area which includes many orphan and niche indications with high unmet medical need. It has one operating segment, namely the development and commercialization of products for the treatment of neuro-ophthalmological, pulmonary and neuromuscular diseases. The company derives the majority of its revenue from the European Union.
---
SPHDF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SPHDF
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
+19.28%
reiterated a buy rating 3 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +19.28% per trade.
---